What is Longview Acquisition Corp. II (LGV) stock price today?

Longview Acquisition Corp. II (LGV) is currently trading at $10.09, up 0.7% today.

What is LGV P/E ratio?

Longview Acquisition Corp. II's P/E ratio is 36.04. This is above the market average, reflecting high growth expectations.

What is LGV return on equity (ROE)?

Longview Acquisition Corp. II's return on equity (ROE) is 3.11%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

NYSE · Shell Companies

Longview Acquisition Corp. II (LGV) Stock

$10.09 +0.70% NYSE: LGV Financial Services

Longview Acquisition Corp. II (LGV), established in 2020 and headquartered in New York City, currently does not conduct any significant operational business.

Valuation

Metric	Value
Price	$10.09
Market Cap	$0
P/E Ratio	36.04
P/B Ratio	1.11
P/S Ratio	0.00
EPS (TTM)	$0.28
52-Week High	$10.15
52-Week Low	$9.68
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	3.11%
ROA	2.89%
ROCE	-0.72%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.25

Annual Financials (USD)

Metric	2021
Revenue	$0
Operating Profit	$-5.0M
Net Profit	$20.0M
EPS	$0.28
Op Margin	—

Balance Sheet (USD)

Metric	2021
Total Assets	$691.0M
Total Liabilities	$46.0M
Cash	$0
Borrowings	$2.0M

Latest News

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors GlobeNewswire · Jul 23, 2026 Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease GlobeNewswire · Jul 13, 2026 Longeveron Names Marie Washburn as CFO MT Newswires · Jul 6, 2026 Longeveron® Appoints Marie Washburn as Chief Financial Officer GlobeNewswire · Jul 6, 2026 New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC) GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric	2021
Operating Cash Flow	$-3.0M
Investing Cash Flow	$-690.0M
Financing Cash Flow	$693.0M
Net Cash Flow	$0
Free Cash Flow	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.11
EV / EBITDA	0.26
FCF Yield	—
Quick Ratio	0.16
Interest Coverage	-33.23
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CCCXChurchill Capital Corp X	$13.66	+0.00%	-6.64	$705.08M	0.00%
CVIIChurchill Capital Corp VII	$9.99	-0.20%	76.85	$914.73M	0.00%
DJT	$9.76	-1.21%	-2.95	$2.70B	0.00%
EOCWElliott Opportunity II Corp.	$10.36	-0.10%	23.55	$789.30M	0.00%
FPACFar Peak Acquisition Corporation	$10.21	+0.10%	6.15	$712.15M	0.00%

About Longview Acquisition Corp. II

Longview Acquisition Corp. II (LGV), established in 2020 and headquartered in New York City, currently does not conduct any significant operational business. Its primary objective is to pursue and finalize a strategic business combination, which could involve a merger, the exchange of capital stock, an acquisition of assets or shares, a corporate reorganization, or a similar transaction with one or more existing companies. The firm intends to concentrate its search for such opportunities within various industries, including healthcare, industrials, consumer products, media, technology, and technology services.

the stock is valued at a price-to-earnings (P/E) ratio of 36.04, price-to-book of 1.11, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.68 and $10.15, and currently trades at its 52-week high.

On profitability, Longview Acquisition Corp. II generates a return on equity (ROE) of 3.11%, return on capital employed of -0.72%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.longviewacquisition.com